Figure 3.

Plasma concentration versus time profiles after intravenous (insert) or oral dosing of gaboxadol to male beagle dogs during 10 h. The dogs received 2.5 mg·kg⁻¹ gaboxadol intravenously or orally (2.5 mg·kg⁻¹; 3.5 mmol·L⁻¹) with tryptophan. Tryptophan was given as a co-administration together with gaboxadol. Data shown are means ± standard error of the mean (n= 6).